COMMUNIQUÉS West-GlobeNewswire

-
Novo Nordisk A/S – Share repurchase programme
29/07/2019 -
FDA Accepts IND Application for Cerecor’s Investigational Drug CERC-802 for the treatment of MPI-CDG
29/07/2019 -
Union Terminal’s Modern Technology Enables a World-Class Experience for Cincinnati Museum Center Visitors
29/07/2019 -
Arrayit Corporation Announces Global Expansion of Finger Stick Health and Wellness Testing Services
29/07/2019 -
Online Muslim Mental Health company TherapyLine that aims to Normalize Mental Health services in the Muslim world launches in the UK, Australia and New Zealand this week.
29/07/2019 -
Share buy-back week 30/2019
29/07/2019 -
Zealand Pharma announces change in corporate management
29/07/2019 -
GENFIT: FDA and EMA Grant GENFIT’s Elafibranor Orphan Drug Designation for Primary Biliary Cholangitis (PBC)
29/07/2019 -
GENFIT : La FDA et l’EMA accordent la désignation d’Orphan Drug à elafibranor pour le traitement de la Cholangite Biliaire Primitive (PBC)
29/07/2019 -
Sanofi delivered solid growth in Q2 2019
29/07/2019 -
Sanofi affiche une croissance solide au deuxième trimestre 2019
29/07/2019 -
Novartis provides update on Phase III PARAGON-HF trial in heart failure patients with preserved ejection fraction (HFpEF)
29/07/2019 -
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
26/07/2019 -
Lexicon Pharmaceuticals Provides Preliminary Update for Zynquista™ (Sotagliflozin) Type 2 Diabetes Phase 3 Program
26/07/2019 -
Diversicare to Announce Second Quarter 2019 Financial Results on Thursday, August 1, 2019
26/07/2019 -
Sanofi : Sanofi provides update on ZynquistaTM (sotagliflozin) type 2 diabetes Phase 3 program and collaboration with Lexicon
26/07/2019 -
Sanofi : Sanofi fournit des informations actualisées sur ZynquistaTM (sotagliflozine) dans le traitement du diabète de type 2 et sa collaboration avec Lexicon
26/07/2019 -
Alder BioPharmaceuticals® Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
26/07/2019 -
priMED Medical Products Appoints Lucas Ethier as Executive Vice President
26/07/2019
Pages